← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
BXP showed modest revenue growth and a net-income rebound, but FCF fell and dividends exceeded FCF in a still-difficult office cycle.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +2.2% to $3.48BNote
- Profitability — Net income +1839.5% to $0.28BOK
- Cash quality — FCF -3.7% to $0.56BWatch
- Margins — Gross margin -77 bpsWatch
- Capital — Dividends -6.8% to $0.64BWatch
- Insiders — 0 buys / 11 sellsWatch
Business
BXP is a publicly traded office REIT focused on premier workplaces. At December 31, 2025, it owned or had joint-venture interests in 179 commercial real estate properties totaling about 52.6M net rentable square feet, concentrated in Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC.
Where the revenue comes from
Fiscal 2025, as BXP, Inc. reports it. History and quarterly detail are in the app.
- Parking and Other$143.3M
- Hotel$50.0M
- Management Service$36.6M
- Real Estate, Other$16.4M
Leadership changes
From BXP, Inc.'s own filings, the day they're filed.
- Retirement Eligibility · CEO · departure
- Qualified Retirement · departure
- Restrictive Covenants · departure
Latest filings
- 8-K · Company announcement2026-08-31
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-05-29
- 8-K · Company announcement2026-05-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BXP, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.